ROBIN BREY

Summary

Affiliation: University of Texas Health Science Center
Country: USA

Publications

  1. ncbi request reprint Management of the neurological manifestations of APS--what do the trials tell us?
    Robin L Brey
    Division of Medicine Neurology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive 7883, San Antonio, TX 78229 3900, USA
    Thromb Res 114:489-99. 2004
  2. ncbi request reprint Animal models for nervous system disease in systemic lupus erythematosus
    R L Brey
    Department of Medicine, University of Texas Health Science Center at San Antonio 78284 7883, USA
    Ann N Y Acad Sci 823:97-106. 1997
  3. ncbi request reprint Neuropsychiatric lupus: clinical and imaging aspects
    Robin L Brey
    Department of Medicine Neurology, University of Texas Health Science Center at San Antonio 78229 3900, USA
    Bull NYU Hosp Jt Dis 65:194-9. 2007
  4. ncbi request reprint Antiphospholipid antibodies in young adults with stroke
    Robin L Brey
    University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78284 7883, USA
    J Thromb Thrombolysis 20:105-12. 2005
  5. ncbi request reprint New treatment option for the antiphospholipid antibody syndrome? More pleiotropic effects of the statin drugs
    R L Brey
    Department of Medicine, Division of Neurology, University of Texas Health Science Center at San Antonio, TX 78229 3900, USA
    J Thromb Haemost 2:1556-7. 2004
  6. doi request reprint Antiphospholipid antibodies and the brain: a consensus report
    R L Brey
    University of Texas Health Science Center at San Antonio, Department of Neurology, San Antonio, TX 78229, USA
    Lupus 20:153-7. 2011
  7. ncbi request reprint Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002
    R L Brey
    Department of Medicine, Division of Neurology, University of Texas Health Science Center San Antonio, Texas 78229 3900, USA
    Lupus 12:508-13. 2003
  8. ncbi request reprint Differential diagnosis of central nervous system manifestations of the antiphospholipid antibody syndrome
    R L Brey
    University of Texas Health Science Center at San Antonio, Texas 78284 7883, USA
    J Autoimmun 15:133-8. 2000
  9. ncbi request reprint Neuropsychiatric syndromes in lupus: prevalence using standardized definitions
    R L Brey
    Department of Medicine, Division of Neurology, San Antonio, TX 78229 3900, USA
    Neurology 58:1214-20. 2002
  10. ncbi request reprint Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke
    Steven R Levine
    Department of Neurology, Mt Sinai School of Medicine, New York, NY 10029 6574, USA
    JAMA 291:576-84. 2004

Research Grants

  1. Cognitive Function in SLE (COGNITION)
    ROBIN BREY; Fiscal Year: 2009
  2. Cognitive Function in SLE (COGNITION)
    ROBIN BREY; Fiscal Year: 2007
  3. MIDCAREER INVESTIGATOR AWARD IN PATIENT-ORIENTED RESEAR
    ROBIN BREY; Fiscal Year: 2006
  4. PREDICTORS OF NEUROPSYCHIATRIC SLE
    ROBIN BREY; Fiscal Year: 2004
  5. Cognitive Function in SLE (COGNITION)
    Robin L Brey; Fiscal Year: 2010

Detail Information

Publications22

  1. ncbi request reprint Management of the neurological manifestations of APS--what do the trials tell us?
    Robin L Brey
    Division of Medicine Neurology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive 7883, San Antonio, TX 78229 3900, USA
    Thromb Res 114:489-99. 2004
    ..To systematically review evidence from clinical trials about the management of neurological manifestations of Antiphospholipid Syndrome (APS)...
  2. ncbi request reprint Animal models for nervous system disease in systemic lupus erythematosus
    R L Brey
    Department of Medicine, University of Texas Health Science Center at San Antonio 78284 7883, USA
    Ann N Y Acad Sci 823:97-106. 1997
    ..Both approaches promise to identify predictors of specific nervous system manifestations that may suggest novel and more specific therapeutic interventions...
  3. ncbi request reprint Neuropsychiatric lupus: clinical and imaging aspects
    Robin L Brey
    Department of Medicine Neurology, University of Texas Health Science Center at San Antonio 78229 3900, USA
    Bull NYU Hosp Jt Dis 65:194-9. 2007
    ..Methods that evaluate metabolic processes and other functional imaging techniques have more promise as surrogates for central nervous system damage. This article reviews the current literature on clinical and imaging aspects of NPSLE...
  4. ncbi request reprint Antiphospholipid antibodies in young adults with stroke
    Robin L Brey
    University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78284 7883, USA
    J Thromb Thrombolysis 20:105-12. 2005
    ..Antiphospholipid antibodies have been associated with a clinical syndrome consisting thrombosis and recurrent, unexplained fetal loss...
  5. ncbi request reprint New treatment option for the antiphospholipid antibody syndrome? More pleiotropic effects of the statin drugs
    R L Brey
    Department of Medicine, Division of Neurology, University of Texas Health Science Center at San Antonio, TX 78229 3900, USA
    J Thromb Haemost 2:1556-7. 2004
  6. doi request reprint Antiphospholipid antibodies and the brain: a consensus report
    R L Brey
    University of Texas Health Science Center at San Antonio, Department of Neurology, San Antonio, TX 78229, USA
    Lupus 20:153-7. 2011
    ..Recommendations are made regarding further research that is needed to clarify remaining uncertainties...
  7. ncbi request reprint Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002
    R L Brey
    Department of Medicine, Division of Neurology, University of Texas Health Science Center San Antonio, Texas 78229 3900, USA
    Lupus 12:508-13. 2003
    ..In the absence of data to guide clinicians on the best treatment, we cannot make strong recommnendations as to optimal therapy, nor can we propose clear consensus treatment guidelines...
  8. ncbi request reprint Differential diagnosis of central nervous system manifestations of the antiphospholipid antibody syndrome
    R L Brey
    University of Texas Health Science Center at San Antonio, Texas 78284 7883, USA
    J Autoimmun 15:133-8. 2000
    ..In this mini-review, most of the neurologic syndromes with an actual or suspected association with aPL are considered. The role of aPL in the differential diagnosis of these syndromes is considered as well...
  9. ncbi request reprint Neuropsychiatric syndromes in lupus: prevalence using standardized definitions
    R L Brey
    Department of Medicine, Division of Neurology, San Antonio, TX 78229 3900, USA
    Neurology 58:1214-20. 2002
    ..The San Antonio Lupus Study of Neuropsychiatric Disease is a longitudinal study designed to characterize the spectrum of and important risk factors for specific neuropsychiatric systemic lupus erythematosus (NPSLE) syndromes...
  10. ncbi request reprint Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke
    Steven R Levine
    Department of Neurology, Mt Sinai School of Medicine, New York, NY 10029 6574, USA
    JAMA 291:576-84. 2004
    ..The presence of antiphospholipid antibodies (aPL) has been associated with vascular occlusive events. However, the role of aPL in predicting ischemic events, particularly recurrent ischemic stroke, is controversial...
  11. ncbi request reprint Neurologic manifestations of the antiphospholipid syndrome: integrating molecular and clinical lessons
    Eyal Muscal
    Department of Medicine Neurology, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229 3900, USA
    Curr Rheumatol Rep 10:67-73. 2008
    ..Modifiable cardiac risk factors and valvular heart disease may worsen APS cerebrovascular outcomes. Adjunctive therapies (eg, statins, antimalarials, and angiotensin-converting enzyme inhibitors) warrant clinical trials...
  12. ncbi request reprint Antiphospholipid antibodies and stroke in young women
    Robin L Brey
    University of Texas Health Science Center, San Antonio, Tex 78229 3900, USA
    Stroke 33:2396-400. 2002
    ..Antiphospholipid antibodies have been associated with ischemic stroke in some but not all studies...
  13. pmc Patent foramen ovale, cardiac valve thickening, and antiphospholipid antibodies as risk factors for subsequent vascular events: the PICSS-APASS study
    Kumar Rajamani
    Department of Neurology, Wayne State University, Detroit, MI 48201, USA
    Stroke 40:2337-42. 2009
    ..PFO is associated with cryptogenic ischemic stroke. Also, the presence of aPL is associated with ischemic cerebrovascular disease...
  14. ncbi request reprint Soluble adhesion molecule levels, neuropsychiatric lupus and lupus-related damage
    Hayden Zaccagni
    Department of Medicine, Division of Neurology and GRECC, South Texas Veterans Health Care System, San Antonio, TX, USA
    Front Biosci 9:1654-9. 2004
    ..Elevated levels of all soluble adhesion molecule levels correlated with abnormal levels of antiphospholipid antibodies, which are associated with some NPSLE manifestations and have been shown to upregulate adhesion molecule expression...
  15. ncbi request reprint Neurologic manifestations of the antiphospholipid syndrome
    Jose F Roldan
    School of Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
    Curr Rheumatol Rep 9:109-15. 2007
    ....
  16. ncbi request reprint Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus (NPSLE)
    David Hermosillo-Romo
    Division of Neurology 7883, 7703 Floyd Curl Drive, San Antonio, Texas 78229 3900, USA
    Best Pract Res Clin Rheumatol 16:229-44. 2002
    ..The management of NPSLE includes symptomatic and/or immunosuppressive treatment strategies depending on the specific presenting neuropsychiatric symptoms and whether these occur in the setting of an SLE disease activity flare...
  17. ncbi request reprint Neuropsychiatric involvement in systemic lupus erythematosus
    David Hermosillo-Romo
    University of Texas Health Science Center at San Antonio, Division of Neurology, Mail Stop 7883, 7703 Floyd Curl Drive, San Antonio, TX 79220 3900, USA
    Curr Rheumatol Rep 4:337-44. 2002
    ..Cognitive dysfunction and psychiatric disorders are the two most common manifestations. The work-up and treatment of nervous system syndromes are also discussed...
  18. ncbi request reprint Both migraine and motion sickness may be due to low brain levels of serotonin
    Robin L Brey
    Neurology 65:E9-10. 2005
    ..In this issue of Neurology, Drummond reports on a study that evaluated whether low brain levels of serotonin trigger motion sickness in people with and without migraine. More information about migraine can be found on the next page...
  19. ncbi request reprint Patient Page. Clinical research needs YOU to help develop new cures!
    Robin L Brey
    Neurology 63:E1. 2004
  20. ncbi request reprint Severe neurologic complications after hematopoietic (peripheral blood) stem cell transplantation in children
    Robin L Brey
    Neurology 59:E13-5. 2002
  21. ncbi request reprint Neuropsychiatric systemic lupus erythematosus: miles to go before we sleep
    Robin L Brey
    Neurology 61:9-10. 2003
  22. ncbi request reprint Patient page. Memory problems after epilepsy surgery
    Stephen L Holliday
    Neurology 60:E3-5. 2003

Research Grants14

  1. Cognitive Function in SLE (COGNITION)
    ROBIN BREY; Fiscal Year: 2009
    ..The information that will be gained from this study is essential for the successful discovery of biological processes that impact on cognitive function in SLE that could be potentially amenable to disease-reversing therapies. ..
  2. Cognitive Function in SLE (COGNITION)
    ROBIN BREY; Fiscal Year: 2007
    ..The information that will be gained from this study is essential for the successful discovery of biological processes that impact on cognitive function in SLE that could be potentially amenable to disease-reversing therapies. ..
  3. MIDCAREER INVESTIGATOR AWARD IN PATIENT-ORIENTED RESEAR
    ROBIN BREY; Fiscal Year: 2006
    ..Much will be learned about the relative importance of genetic factors and autoantibodies on vascular disease risk in SLE that is likely to apply to other populations also at increased risk for cerebral ischemia and vascular dementia. ..
  4. PREDICTORS OF NEUROPSYCHIATRIC SLE
    ROBIN BREY; Fiscal Year: 2004
    ..The information gained will bridge important gaps in our knowledge about NS involvement in SLE and will lead to new hypothesis-driven studies of etiopathogenesis and treatment. ..
  5. Cognitive Function in SLE (COGNITION)
    Robin L Brey; Fiscal Year: 2010
    ..The information that will be gained from this study is essential for the successful discovery of biological processes that impact on cognitive function in SLE that could be potentially amenable to disease-reversing therapies. ..